Veristat and Cidara Therapeutics Collaborate with a Preferred Provider Agreement
Veristat to Assist Cidara with Its Trials for Novel Echinocandin Antifungal CD101
Veristat Continues Decade Long Preferred Partnership with EndoCeutics
Veristat Assists EndoCeutics with NDA Submission for Intravaginal Prasterone
Veristat Recognized as One of America’s Fast-Growing Companies on the 2015 Inc. 5000 List
Veristat announced that it has been recognized by Inc. Magazine as one of the Countries’ fastest-growing private companies.
Veristat Completes Move into New Corporate Headquarters
SOUTHBOROUGH, MA – July 13, 2015 – Veristat, a full service Clinical Research Organization (CRO), announced today that it has completed the...
Veristat Expands Its San Francisco Bay Area Operations: Opens New Office to Support Life...
HOLLISTON, MA – June 15, 2015 – Veristat, a full service Clinical Research Organization (CRO), announced today that it has opened a new...
Veristat Growth and Service Demand Drive Expansion: Veristat to Move Corporate Headquarters
Veristat will Move Corporate Headquarters to Southborough, MA This Summer
National Association of Professional Women Announces Cynthia Henderson, Executive Vice...
Cynthia Henderson is recognized as an NAPW VIP Woman of the Year for her outstanding leadership and commitment within her profession
Garden...